The US Senate is likely to consider S. 982 (Kennedy's FDA tobacco bill) during the week of June 2.
It is important to know that passage of the legislation will have no negative legal or regulatory impact on e-cigarettes. One of my goals, which now appears unlikely, was to amend the legislation to prevent the FDA from banning e-cigarettes as drug devices (by defining e-cigarettes as a new category of tobacco product).
But the legislation's ban on new smokefree tobacco products (and the false claims by Senate Democrats that Reynolds is target marketing these products to youth) could encourage the FDA to further crack down on e-cigarettes (than if the tobacco legislation weren't enacted).
Sen. Coburn offered, then withdrew, his amendment (i.e. the ECA amendment) that would exempt e-cigarettes from the definition of a tobacco product, during Wednesday night's HELP Cmte markup session (the session that isn't available on the committee's website). Coburn will try negotiating an agreement with Dodd on that amendment prior to Senate floor consideration.
But since S. 982 doesn't define e-cigarettes as a tobacco product (or otherwise apply to e-cigarettes), I'm not convinced that passage of the Coburn amendment would provide any legal or regulatory benefits for e-cigarettes (as the FDA could still rule that e-cigarettes, or certain e-cigarette products, are unapproved drug devices, and take action).